biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
17:44 Lab study points to a protein that may help drive aging in testicles✦17:43 Trial will test whether stool-transplant capsules slow aging in 68 adults✦17:39 Novartis pill cut MS relapses more than an older drug in two big trials✦11:36 Women on menopause hormones lost a bit more weight on Ozempic-style drugs✦05:37 Sugar found mostly in red meat tied to higher diabetes risk in early study✦05:34 AI readings of heart MRIs slightly beat doctors at flagging death risk✦17:39 Drug that cut an inherited cholesterol particle missed its main heart goal✦11:39 Breast cancer drug shrank tumors in 5 of 10 after Enhertu, makers say✦17:44 Lab study points to a protein that may help drive aging in testicles✦17:43 Trial will test whether stool-transplant capsules slow aging in 68 adults✦17:39 Novartis pill cut MS relapses more than an older drug in two big trials✦11:36 Women on menopause hormones lost a bit more weight on Ozempic-style drugs✦05:37 Sugar found mostly in red meat tied to higher diabetes risk in early study✦05:34 AI readings of heart MRIs slightly beat doctors at flagging death risk✦17:39 Drug that cut an inherited cholesterol particle missed its main heart goal✦11:39 Breast cancer drug shrank tumors in 5 of 10 after Enhertu, makers say
← All story threadsSTORY THREAD

Novartis's daily pill for multiple sclerosis.

1 report so far. New developments are added to this thread as they happen.

  1. Nov 3, 2026
    BEAT AN OLDER MS PILL ON RELAPSES IN TWO BIG TRIALSTwo trials · ~2,000 adults

    Novartis pill cut MS relapses more than an older drug in two big trials

    In two large trials of about 2,000 adults, a daily Novartis pill for multiple sclerosis led to fewer relapses and fewer new brain spots on scans than the older pill Aubagio.